Healthcare AI investors writing $25M+ checks
Investors whose typical check size falls in the $25M+ range for healthcare AI deals. Useful for sizing your round and identifying the right tier of partners.
Checks exceeding $25 million characterize extreme late-stage mega-rounds (Series C, D, and beyond) or massive private equity buyouts. In the AI and MedTech sectors, this capital supports profound infrastructural development, global scaling, and massive clinical deployments.
145
investors match
Within $25M+: top investment stages
Australian Future Fund
PE
T3
Digital Health
Pharma / Therapeutics
Ayala Ventures
Corporate VC
T2
Care Delivery / Tech-Enabled Services
Pharma / Therapeutics
Balyasny Asset Management
PE
T3
Biotech
Pharma / Therapeutics
BayPine
PE
T3
Care Delivery / Tech-Enabled Services
Digital Health
Blackstone Group
PE
T1
Care Delivery / Tech-Enabled Services
Life Sciences Tools
BPOC
PE
T3
Care Delivery / Tech-Enabled Services
Brookfield Asset Management
PE
T3
Care Delivery / Tech-Enabled Services
BV Investment Partners
PE
T3
Health IT / Healthcare Software
CDH Investments
PE
T3
Care Delivery / Tech-Enabled Services
Pharma / Therapeutics
Charlesbank Capital Partners
PE
T3
Care Delivery / Tech-Enabled Services
China Life Insurance
Corporate VC
T3
Care Delivery / Tech-Enabled Services
Digital Health
ChrysCapital
PE
T2
Health IT / Healthcare Software
Pharma / Therapeutics
Cinven
PE
T3
Diagnostics
Pharma / Therapeutics
Clayton Dubilier & Rice
PE
T3
Care Delivery / Tech-Enabled Services
Comvest Partners
PE
T3
Care Delivery / Tech-Enabled Services